Another important regulatory pathway is the NF-κB pathway, in which the deacetylation and repression of NF-κB signaling by SIRT1 promote adaptive redox balance and anti-apoptotic responses in sorafenib-resistant HCC (205). The gene discussed is NFKB1; the disease is hepatocellular carcinoma.